Keywords
vaccines
SARS-CoV-2
Transplant Recipients
Renal Dialysis
How to Cite
Abstract
Background: People on dialysis are considered a high-risk population for SARS-CoV-2 infection, complications, and death. In Colombia, about 44% of the population on dialysis is under 60 years of age. In addition, due to the same challenges that the pandemic has imposed on transplant programs, the young population that must continue on dialysis has increased markedly, as they have no option in the short term of a kidney transplant, therefore, the limitations in early access to vaccination against SARS-CoV-2 would exacerbate the problems of this population, causing considerable losses in years of life that the vaccine could save.
Purpose: The objective of this document is to summarize the main reasons why the prioritization of vaccination of patients on chronic dialysis and on the kidney transplant waiting list is recommended.
Methodology: A rapid search for information on vaccination in patients with CKD on dialysis or awaiting kidney transplantation was performed. The resulting information was critically analyzed by experts in nephrology for the formulation of recommendations. The search results are presented as a narrative synthesis.
Results: Based on the information reviewed and discussed by nephrology experts, 4 recommendations are proposed for vaccination against the SARS-Cov-2 virus.
Conclusions: The Colombian Association of Nephrology and Arterial Hypertension (ASOCOLNEF), the Colombian Association of Pediatric Nephrology (ACONEPE) and the Colombian Association of Organ Transplantation (ACTO), committed to the health of patients with kidney disease on dialysis and transplant waiting lists in Colombia, join to generate recommendations for prioritization and vaccination against SARS-CoV-2.
References
Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Post discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2020 jul. 93(2):1013-22. https://doi.org/10.1002/jmv.26368
De Meester J, De Bacquer D, Naesens M, Meijers B, Couttenye M. Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: a region wide registry study. J Am Soc Nephrol. 2021; 32:385-96. https://doi.org/10.1681/ASN.2020060875
Peck M et al. Global routine vaccination coverage [Internet]. Available from: https://www.cdc.gov/mmwr/volumes/68/wr/mm6842a1.htm?s_cid=mm6842a1_x
WHO. Immunization coverage [Internet]. 2020. Disponible en: http://www.who.int/news-room/fact-sheets/detail/immunization-coverage
Tan W, Zhao X, Ma X, Wang W, Niu P, Xu W, et al. A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases - Wuhan, China 2019-2020. China CDC Wkly. 2020;2(4):61-2. https://doi.org/10.46234/ccdcw2020.017
WHO. Draft landscape of COVID-19 candidate vaccines [Internet]. 2020. Disponible en: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
Francis A, Baigent C, Ikizler TA, Cockwell P, Jha V. The urgent need to vaccinate dialysis patients against SARS-CoV-2: A call to action. Kidney Int. 2021;99(4):791-3. https://doi.org/10.1016/j.kint.2021.02.003
National Kidney Foundation. Position Statement on Kidney Patient Prioritization for COVID-19 Vaccines and Therapeutics [Internet]. 2021. Disponible en: https://www.kidney.org/sites/default/files/nkf_statement_vaccine_distribution_final_20201216.pdf
Gansevoort RT, Hilbrands LB. CKD is a key risk factor for COVID-19 mortality. Nature Rev Nephrol. 2020;16(12):705-6. https://doi.org/10.1038/s41581-020-00349-4
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430-6. https://doi.org/10.1038/s41586-020-2521-4
Bruchfeld A. The COVID-19 pandemic: consequences for nephrology. Nat Rev Nephrol. 2020;1-2. https://doi.org/10.1038/s41581-020-00381-4
Sim JJ, Huang CW, Selevan DC, Chung J, Rutkowski MP, Zhou H. COVID-19 and Survival in Maintenance Dialysis. Kidney Med. 2020. https://doi.org/10.1016/j.xkme.2020.11.005
González C, Yama E, Yomayusa N, Vargas J, Rico J, Ariza A, et al. Consenso colombiano de expertos sobre recomendaciones informadas en la evidencia para la prevención, el diagnóstico y el manejo de la lesión renal aguda por SARS-CoV-2/COVID-19. Rev Colomb Nefrol. 2020;7(supl. 2). https://doi.org/10.22265/acnef.7.Supl.2.473
Yomayusa N, Yama E, González C, Ariza A, Aroca G, Baquero R, et al. Consenso colombiano de expertos sobre recomendaciones informadas en la evidencia para la prevención, diagnóstico y manejo de infección por SARS-CoV-2/COVID-19 en pacientes con Enfermedad Renal Crónica en diálisis. Rev Colomb Nefrol. 2020 jul.;7(supl. 2). https://doi.org/10.22265/acnef.7.Supl.2.474
Baquero R, Yomayusa N, González C, Yama E, Vargas JG, Rico J, et al. Consenso colombiano de expertos sobre recomendaciones informadas en la evidencia para la prevención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en paciente pediátrico con enfermedad renal crónica o lesión renal aguda asociada a COVID-19. Rev Colomb Nefrol. 2020 jul.;7(supl. 2). https://doi.org/10.22265/acnef.7.Supl.2.488
Cuenta de Alto Costo (CAC). Situación de la enfermedad Renal Crónica, Hipertensión arterial y Diabetes Mellitus en Colombia. 2018. Disponible en: https://cuentadealtocosto.org/site/publicaciones/situacion-de-la-enfermedad-renal-cronica-la-hipertension-arterial-y-la-diabetes-mellitus-en-colombia-2018/
Khatri M, Islam S, Dutka P, Carson J, Drakakis J, Imbriano I, et al. COVID-19 Antibodies and Outcomes among Outpatient Maintenance Hemodialysis Patients. Kidney360. 2021;2(2):263-9. https://doi.org/10.34067/KID.0006292020
Couchoud C, Bayer F, Ayav C, Béchade C, Brunet P, Chantrel F, et al. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients. Kidney Int. 2020;98(6):1519-29. https://doi.org/10.1016/j.kint.2020.07.042
Weiss S, Bhat P, Del Pilar-Fernández M, Bhat JG, Coritsidis GN. COVID-19 Infection in ESKD: Findings from a Prospective Disease Surveillance Program at Dialysis Facilities in New York City and Long Island. J Am Soc Nephrol. 2020;31(11):2517-21. https://doi.org/10.1681/ASN.2020070932
Hsu CM, Weiner DE, Aweh G, Miskulin D, Manley H, Stewart C, et al. COVID-19 Infection Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider. Am J Kidney Dis. 2021;77(5):748-56. https://doi.org/10.1053/j.ajkd.2021.01.003
Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV2 infection. Kidney Int. 2020;98(1):20-6. https://doi.org/10.1016/j.kint.2020.04.030
Corbett RW, Blakey S, Nitsch D, Loucaidou M, McLean A, Duncan N, et al. Epidemiology of COVID-19 in an Urban Dialysis Center. J Am Soc Nephrol. 2020;31(8):1815-23. https://doi.org/10.1681/ASN.2020040534
Ng JH, Hirsch JS, Wanchoo R, Sachdeva M, Sakhiya V, Hong S, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98(6):1530-9. https://doi.org/10.1016/j.kint.2020.07.030
Turgutalp K, Ozturk S, Arici M, Eren N, Gorgulu N, Islam N, et al. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19. BMC Nephrol. 2021;22(1):29. https://doi.org/10.1186/s12882-021-02233-0
Ozturk S, Turgutalp K, Arici M, Odabas A, Altiparmal M, Audin Z, et al. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey. Nephrol Dial Transpl. 2020;35(12):2083-95. https://doi.org/10.1093/ndt/gfaa271
Flythe JE, Assimon MM, Tugman MJ, Chang E, Gupta S, Shah J, et al. Characteristics and Outcomes of Individuals with Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States. Am J Kidney Dis. 2021;77(2):190-203. https://doi.org/10.1053/j.ajkd.2020.09.003
Savino M, Casula A, Santhakumaran S, Pitcher D, Wong E, Magadi W, et al. Sociodemographic features and mortality of individuals on haemodialysis treatment who test positive for SARSCoV-2: a UK Renal Registry data analysis. PLoS One. 2020;15:e0241263. https://doi.org/10.1371/journal.pone.0241263
Arias-Murillo YR, Benavides CA, Salinas MA, Osorio-Arango K, Plazas-Sierra C, Cortés JA. SARS-CoV2/COVID-19 Infection in Transplant Recipients and in Patients on the Organ Transplant Waiting List in Colombia. Transplant Proc. 2021;53(4):1237-44. https://doi.org/10.1016/j.transproceed.2020.12.003
Pastor-Barriuso R, Pérez-Gómez B, Hernán MA, Pérez-Olmeda M, Yotti R, Oteo-Iglesias J, et al. Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study. BMJ. 2020 nov. 27;371. https://doi.org/10.1136/bmj.m4509
Caillard S, Anglicheau D, Matignon M, Durrbach A, Greze C, Frimat L, et al. An initial report from the French SOT COVID registry suggest high mortality due to COVID 19 in recipients of kidney transplant. Kidney Int. 2020;98:1549-58. https://doi.org/10.1016/j.kint.2020.08.005
Akalin E, Azzi Y, Bartash R, Seethamraju H, Parides M, Hemmige V, et al. Covid-19 and Kidney Transplantation. N Engl J Med. 2020;382(25):2475-7. https://doi.org/10.1056/NEJMc2011117
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.